Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COMMON STOCK-FO
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
22.8M
-
Shares change
-
+1.62M
-
Total reported value, excl. options
-
$544M
-
Value change
-
+$38.8M
-
Number of buys
-
15
-
Number of sells
-
-11
-
Price
-
$23.87
Significant Holders of MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) as of Q1 2019
36 filings reported holding MYOV - MYOVANT SCIENCES LTD - COMMON STOCK-FO as of Q1 2019.
MYOVANT SCIENCES LTD - COMMON STOCK-FO (MYOV) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.8M shares
.
Largest 10 shareholders include BB BIOTECH AG (3.6M shares), RA CAPITAL MANAGEMENT, LLC (3.54M shares), NovaQuest Capital Management, L.L.C. (3.47M shares), JANUS HENDERSON GROUP PLC (2.51M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.47M shares), LORD, ABBETT & CO. LLC (1.97M shares), VICTORY CAPITAL MANAGEMENT INC (842K shares), PRICE T ROWE ASSOCIATES INC /MD/ (812K shares), NORGES BANK (750K shares), and Cormorant Asset Management, LP (650K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.